The New Zealand Herald

Meridian a standout as index cools off

Generator powers to fresh record as F&P and a2 slide

- Graham Skellern

Meridian Energy, continuing to test new highs, stood out as the New Zealand sharemarke­t settled into a calmer mode following an action-packed, record-setting November.

After trading in positive territory for most of the day, the S&P/NZX 50 Index slid late, closing down 1.22 points or 0.01 per cent to 12,728.69. The intraday high was 12,799.89 points. There were 77 gainers and 64 decliners, and trading was solid with 90.04 million shares worth $191.75 million changing hands.

Jeremy Sullivan, investment adviser with Hamilton Hindin Greene, said “we had a very strong November with all-time highs all over the place and the markets can’t keep going up in a straight line.

“The strong run has led to some profit-taking and the market is probably due a correction. With institutio­nal investors going away for the holidays, we may see lower trading volumes in the lead-in to Christmas and this could push some stocks around,” he said. Meridian, the market’s second biggest stock on capitalisa­tion, is unperturbe­d. It is now trading at a record high, rising 9c to $6.53 on trade worth $17.2m, after reaching an intraday high of $6.60. Meridian has climbed from the March 23 low of $3.87. Of fellow energy stocks, Contact was up 6c to $7.92, and Vector increased 5c to $4.25.

Contact said its gas supplies from the offshore Pohokura and Maui fields for 2021 will be down by about a quarter, after operator OMV said it is reducing the expected supply to Contact by 3.7 petajoules to 10.6 petajoules. Contact, like all generators, is moving to reduce its use of gas, but gas still made up 16 per cent of its supply in the year ending June.

Leading stock Fisher & Paykel Healthcare had another down day, falling 56c to $34.95.

The a2 Milk Company continued its slide, falling 19c to $14.02 on trade worth $13.5m, after reaching a high of $21.51 on July 30. Sullivan said a2 Milk still has issues with the daigou sales channel, and the company set some lofty expectatio­ns for the second half of the financial year.

Juggernaut Mainfreigh­t gained 6c to $61.08; Freightway­s was up 5c to $9.35; Summerset Group Holdings increased 30c or 2.82 per cent to $10.92; Serko picked up 7c to $5.43;

SkyCity Entertainm­ent rose 5c to $3.11; and AFT Pharmaceut­icals was up 9c or 1.95 per cent to $4.71. Manukau honey producer Comvita and

Heartland Group Holdings continued a rally, rising 6c or 1.81 per cent to $3.38, and 5c or 3.38 per cent to $1.53 respective­ly.

Synlait Milk slipped 17c or 3.18 per cent to $5.17, and new listing

Harmoney fell further, declining 9c or 2.72 per cent to $3.22.

Pacific Edge, which has developed a non-invasive test for bladder cancer, climbed 5c or 7.14 per cent to 75c after broker Jarden put out a research note suggesting its share price could double to $1.40 within 12 months, based on strong prospects in the United States market.

NZX said its 2020 operating earnings (ebitda) is expected to be near the top of the guidance range of $30m-$33.5m, and its share price slipped 1c to $1.84.

 ??  ??

Newspapers in English

Newspapers from New Zealand